Comparison	comparison	O	O	O	O
of	of	O	O	O	O
unilateral	unilateral	O	O	O	O
pallidotomy	pallidotomy	O	O	O	O
and	and	O	O	O	O
subthalamotomy	subthalamotomy	O	O	O	O
findings	findings	O	O	O	O
in	in	O	O	O	O
advanced	advanced	O	O	O	O
idiopathic	idiopathic	O	DISEASE	OTHERS	I
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
prospective	prospective	O	O	O	O
,	,	O	O	O	O
randomized	randomized	O	O	O	O
,	,	O	O	O	O
double-blind	double-blind	O	O	O	O
pilot	pilot	O	O	O	O
study	study	O	O	O	O
to	to	O	O	O	O
compare	compare	O	O	O	O
the	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
stereotactic	stereotactic	O	O	O	O
unilateral	unilateral	O	O	O	O
pallidotomy	pallidotomy	O	O	O	O
and	and	O	O	O	O
subthalamotomy	subthalamotomy	O	O	O	O
in	in	O	O	O	O
advanced	advanced	O	O	O	O
idiopathic	idiopathic	O	DISEASE	OTHERS	I
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
(	(	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
)	)	O	O	O	O
refractory	refractory	O	O	O	O
to	to	O	O	O	O
medical	medical	O	O	O	O
treatment	treatment	O	O	O	O
was	was	O	O	O	O
designed	designed	O	O	O	O
.	.	O	O	O	O

Ten	ten	O	O	O	O
consecutive	consecutive	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
age	age	O	O	O	O
,	,	O	O	O	O
58.4	58.4	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
6.8	6.8	O	O	O	O
years	years	O	O	O	O
;	;	O	O	O	O
7	7	O	O	O	O
men	men	O	O	O	O
,	,	O	O	O	O
3	3	O	O	O	O
women	women	O	O	O	O
)	)	O	O	O	O
with	with	O	O	O	O
similar	similar	O	O	O	O
characteristics	characteristics	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
disease	disease	O	O	O	O
(	(	O	O	O	O
mean	mean	O	O	O	O
disease	disease	O	O	O	O
time	time	O	O	O	O
,	,	O	O	O	O
8.4	8.4	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
3.5	3.5	O	O	O	O
years	years	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
disabling	disabling	O	O	O	O
motor	motor	O	O	O	O
fluctuations	fluctuations	O	O	O	O
(	(	O	O	O	O
Hoehn	hoehn	O	O	O	O
_	_	O	O	O	O
Yahr	yahr	O	O	O	O
stage	stage	O	O	O	O
3	3	O	O	O	O
-	-	O	O	O	O
5	5	O	O	O	O
in	in	O	O	O	O
off-drug	off-drug	O	O	O	O
phases	phases	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
levodopa-induced	levodopa-induced	O	O	O	O
dyskinesias	dyskinesias	O	DISEASE	OTHERS	I
were	were	O	O	O	O
selected	selected	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
bilateral	bilateral	O	O	O	O
symptoms	symptoms	O	O	O	O
and	and	O	O	O	O
their	their	O	O	O	O
levodopa	levodopa	CHEMICALS	O	OTHERS	I
equivalent	equivalent	O	O	O	O
dosing	dosing	O	O	O	O
were	were	O	O	O	O
analysed	analysed	O	O	O	O
.	.	O	O	O	O

Six	six	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
operated	operated	O	O	O	O
on	on	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
globus	globus	O	O	O	O
pallidus	pallidus	O	O	O	O
interna	interna	O	O	O	O
(	(	O	O	O	O
GPi	gpi	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
four	four	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
subthalamic	subthalamic	O	O	O	O
nucleus	nucleus	O	O	O	O
(	(	O	O	O	O
STN	stn	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Clinical	clinical	O	O	O	O
evaluation	evaluation	O	O	O	O
included	included	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
Unified	unified	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
Disease	disease	O	DISEASE	OTHERS	I
Rating	rating	O	O	O	O
Scale	scale	O	O	O	O
(	(	O	O	O	O
UPDRS	updrs	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
Hoehn_Yahr	hoehn_yahr	O	O	O	O
score	score	O	O	O	O
and	and	O	O	O	O
Schwab	schwab	O	O	O	O
England	england	O	O	O	O
activities	activities	O	O	O	O
of	of	O	O	O	O
daily	daily	O	O	O	O
living	living	O	O	O	O
(	(	O	O	O	O
ADL	adl	O	O	O	O
)	)	O	O	O	O
score	score	O	O	O	O
in	in	O	O	O	O
'	'	O	O	O	O
on'-	on'-	O	O	O	O
and	and	O	O	O	O
'	'	O	O	O	O
off'-drug	off'-drug	O	O	O	O
conditions	conditions	O	O	O	O
before	before	O	O	O	O
surgery	surgery	O	O	O	O
and	and	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
after	after	O	O	O	O
surgery	surgery	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
was	was	O	O	O	O
statistically	statistically	O	O	O	O
significant	significant	O	O	O	O
improvement	improvement	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
contralateral	contralateral	O	O	O	O
major	major	O	O	O	O
parkinsonian	parkinsonian	O	DISEASE	OTHERS	I
motor	motor	O	O	O	O
signs	signs	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
patients	patients	O	O	O	O
followed	followed	O	O	O	O
for	for	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

Levodopa	levodopa	CHEMICALS	O	OTHERS	I
equivalent	equivalent	O	O	O	O
daily	daily	O	O	O	O
intake	intake	O	O	O	O
was	was	O	O	O	O
significantly	significantly	O	O	O	O
reduced	reduced	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
STN	stn	O	O	O	O
group	group	O	O	O	O
.	.	O	O	O	O

Changes	changes	O	O	O	O
in	in	O	O	O	O
UPDRS	updrs	O	O	O	O
,	,	O	O	O	O
Hoehn	hoehn	O	O	O	O
_	_	O	O	O	O
Yahr	yahr	O	O	O	O
and	and	O	O	O	O
Schwab	schwab	O	O	O	O
England	england	O	O	O	O
ADL	adl	O	O	O	O
scores	scores	O	O	O	O
were	were	O	O	O	O
similar	similar	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

Cognitive	cognitive	O	O	O	O
functions	functions	O	O	O	O
were	were	O	O	O	O
unchanged	unchanged	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

Complications	complications	O	O	O	O
were	were	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
two	two	O	O	O	O
patients	patients	O	O	O	O
:	:	O	O	O	O
one	one	O	O	O	O
had	had	O	O	O	O
a	a	O	O	O	O
left	left	O	O	O	O
homonymous	homonymous	O	O	OTHERS	I
hemianopsia	hemianopsia	O	O	OTHERS	I
after	after	O	O	O	O
pallidotomy	pallidotomy	O	O	O	O
and	and	O	O	O	O
another	another	O	O	O	O
one	one	O	O	O	O
developed	developed	O	O	O	O
left	left	O	O	O	O
hemiballistic	hemiballistic	O	O	O	O
movements	movements	O	O	O	O
3	3	O	O	O	O
days	days	O	O	O	O
after	after	O	O	O	O
subthalamotomy	subthalamotomy	O	O	O	O
which	which	O	O	O	O
partly	partly	O	O	O	O
improved	improved	O	O	O	O
within	within	O	O	O	O
1	1	O	O	O	O
month	month	O	O	O	O
with	with	O	O	O	O
Valproate	valproate	CHEMICALS	O	OTHERS	I
1000	1000	O	O	O	O
mg/day	mg/day	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
findings	findings	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
lesions	lesions	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
unilateral	unilateral	O	O	O	O
STN	stn	O	O	O	O
and	and	O	O	O	O
GPi	gpi	O	O	O	O
are	are	O	O	O	O
equally	equally	O	O	O	O
effective	effective	O	O	O	O
treatment	treatment	O	O	O	O
for	for	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
advanced	advanced	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
refractory	refractory	O	O	O	O
to	to	O	O	O	O
medical	medical	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

